Changing the tumor microenvironment: new strategies for immunotherapy

Solid tumors are composed of malignant cells surrounded by a tumor-conditioned stroma that contains extracellular matrix and a variety of nonmalignant populations, including myeloid cells, lymphocytes, fibroblasts, and endothelial cells. These stromal elements form a local immunoregulatory network t...

Full description

Saved in:
Bibliographic Details
Main Authors: Berraondo, Pedro (Author) , Umansky, Viktor (Author) , Melero, Ignacio (Author)
Format: Article (Journal)
Language:English
Published: July 23, 2012
In: Cancer research
Year: 2012, Volume: 72, Issue: 20, Pages: 5159-5164
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-12-1952
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1158/0008-5472.CAN-12-1952
Verlag, kostenfrei, Volltext: http://cancerres.aacrjournals.org/content/72/20/5159
Get full text
Author Notes:Pedro Berraondo, Viktor Umansky, and Ignacio Melero
Description
Summary:Solid tumors are composed of malignant cells surrounded by a tumor-conditioned stroma that contains extracellular matrix and a variety of nonmalignant populations, including myeloid cells, lymphocytes, fibroblasts, and endothelial cells. These stromal elements form a local immunoregulatory network that must be overcome to achieve eradication of established tumors by immunotherapy. On March 21-22, 2012, a symposium was held in Pamplona, Spain, to share the recent advances regarding the molecules and cells that create and sustain this immune-hostile tumor microenvironment. Excellent targets for immunotherapeutic intervention were identified, and a number of therapeutic strategies under translation from mouse to human were presented. Cancer Res; 72(20); 5159-64. ©2012 AACR.
Item Description:Gesehen am 30.05.2018
Physical Description:Online Resource
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-12-1952